Comprehensive Complication Index Versus Clavien-Dindo Classification After CRS-HIPEC for Colorectal Peritoneal Metastases: Associations with 30- and 90-Day Readmission.
- 1Department of General Surgery, Division of Surgical Oncology, Faculty of Medicine, Çukurova University, 01330 Adana, Türkiye.
- 2Division of Gastroenterological Surgery, Adana City Training and Research Hospital, 01230 Adana, Türkiye.
- 3Department of General Surgery, Faculty of Medicine, Çukurova University, 01330 Adana, Türkiye.
Abstract
Background and Objectives: To compare the Comprehensive Complication Index (CCI) with the conventional Clavien-Dindo (CD) classification for association with readmission after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for colorectal peritoneal metastases. Materials and Methods: Single-center retrospective cohort of 26 patients treated with CRS-HIPEC for peritoneal metastases of colonic or rectal origin. The patient-level CD grade was the highest of the individually graded complications of the index admission; the CCI was calculated with the standard formula. A prespecified threshold of CCI ≥ 26.2-the value of a single CD grade IIIa complication-defined a high cumulative burden. Unplanned readmission was assessed at 30 and 90 days after discharge as co-primary outcomes; classification agreement and correlates of CCI level were exploratory, without adjustment for multiplicity. Results: Agreement was moderate (kappa = 0.54, 95% confidence interval [CI] 0.25-0.83). Six of 26 patients (23.1%) had no major complication by the CD classification yet a high cumulative burden by the CCI (exact McNemar p = 0.031). Readmission occurred in 32.0% by 30 days and 44.0% by 90 days. For 90-day readmission the CCI gave a numerically higher area under the curve than the CD classification (0.672 vs. 0.555; DeLong p = 0.074), and readmission was more frequent above the CCI threshold (55.6% vs. 14.3%; odds ratio 6.95, 95% CI 0.64-378.69); neither comparison was significant. CCI level correlated with body mass index (rho = 0.541) and the Peritoneal Cancer Index (rho = 0.423), both p < 0.05. Conclusions: The CCI identified a high cumulative burden in six patients recorded as having no major complication by the CD classification, but its numerically higher discrimination for readmission was not statistically demonstrated. These exploratory findings require confirmation in larger cohorts.
Related
- Association Between the Preoperative Modified Frailty Index-5 and Cumulative Morbidity After Colorectal Cancer Resection: A Single-Center Retrospective Cohort Study Based on the Comprehensive Complication Index
- Comparison of postoperative outcomes of whole liver transplantation and split liver transplantation using the Comprehensive Complication Index®
- Routine blood-based immune signatures in endogenous Cushing’s syndrome: associations with cortisol excess and selected complication burden
- Perioperative Intravenous Antibiotic Regimens and Surgical Site Infection After Colorectal Surgery: Clinical Associations and External Evaluation of Risk Prediction Models
- Associations and Similarities Between Breast Cancer and Vulvar Cancer: A Comprehensive Literature Review
BibTeX
@article{topal2026comprehensive,
title = {{Comprehensive Complication Index Versus Clavien-Dindo Classification After CRS-HIPEC for Colorectal Peritoneal Metastases: Associations with 30- and 90-Day Readmission.}},
author = {Uğur Topal and İbrahim Çoğal and Yunus Kaycı and İshak Aydın and Serdar Gümüş and Orçun Yalav and İsmail Cem Eray and Cem Kaan Parsak},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
month = oct,
doi = {10.3390/medicina62101935},
url = {https://europepmc.org/article/MED/42942466},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comprehensive Complication Index Versus Clavien-Dindo Classification After CRS-HIPEC for Colorectal Peritoneal Metastases: Associations with 30- and 90-Day Readmission.
AU - Uğur Topal
AU - İbrahim Çoğal
AU - Yunus Kaycı
AU - İshak Aydın
AU - Serdar Gümüş
AU - Orçun Yalav
AU - İsmail Cem Eray
AU - Cem Kaan Parsak
PY - 2026
DA - 2026/10/07
JO - Medicina (Kaunas, Lithuania)
DO - 10.3390/medicina62101935
UR - https://europepmc.org/article/MED/42942466
AB - Background and Objectives: To compare the Comprehensive Complication Index (CCI) with the conventional Clavien-Dindo (CD) classification for association with readmission after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for colorectal peritoneal metastases. Materials and Methods: Single-center retrospective cohort of 26 patients treated with CRS-HIPEC for peritoneal metastases of colonic or rectal origin. The patient-level CD grade was the highest of the individually graded complications of the index admission; the CCI was calculated with the standard formula. A prespecified threshold of CCI ≥ 26.2-the value of a single CD grade IIIa complication-defined a high cumulative burden. Unplanned readmission was assessed at 30 and 90 days after discharge as co-primary outcomes; classification agreement and correlates of CCI level were exploratory, without adjustment for multiplicity. Results: Agreement was moderate (kappa = 0.54, 95% confidence interval [CI] 0.25-0.83). Six of 26 patients (23.1%) had no major complication by the CD classification yet a high cumulative burden by the CCI (exact McNemar p = 0.031). Readmission occurred in 32.0% by 30 days and 44.0% by 90 days. For 90-day readmission the CCI gave a numerically higher area under the curve than the CD classification (0.672 vs. 0.555; DeLong p = 0.074), and readmission was more frequent above the CCI threshold (55.6% vs. 14.3%; odds ratio 6.95, 95% CI 0.64-378.69); neither comparison was significant. CCI level correlated with body mass index (rho = 0.541) and the Peritoneal Cancer Index (rho = 0.423), both p < 0.05. Conclusions: The CCI identified a high cumulative burden in six patients recorded as having no major complication by the CD classification, but its numerically higher discrimination for readmission was not statistically demonstrated. These exploratory findings require confirmation in larger cohorts.
SN - 1010-660X
SN - 1648-9144
ER -